Description
UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. DEOBLIGATE (REMOVE) EXCESS FUNDS / OPTION YEAR FOUR
Base award description: IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL.
Modification chain · 15 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-10-01+$79,259= $79,259
- Mod P000012017-09-30+$0= $79,259
- Mod P000022017-10-01+$79,259= $158,519
- Mod P000032018-02-09-$32,961= $125,558
- Mod P000042018-09-18+$0= $125,558
- Mod P000052018-10-01+$88,951= $214,509
- Mod P000062018-12-14-$28,339= $186,170
- Mod P000072019-06-06+$0= $186,170
- Mod P000082019-09-20+$0= $186,170
- Mod P000092019-10-01+$124,188= $310,358
- Mod P000102020-05-04-$58,025= $252,333
- Mod P000112020-09-01+$0= $252,333
- Mod P000122020-10-01+$124,188= $376,521
- Mod P000132021-01-27+$0= $376,521
- Mod P000142022-02-10-$29,772= $346,750
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-10-01 | +$79,259 | $79,259 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00001· EXERCISE AN OPTION | 2017-09-30 | +$0 | $79,259 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00002· EXERCISE AN OPTION | 2017-10-01 | +$79,259 | $158,519 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-02-09 | −$32,961 | $125,558 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00004· EXERCISE AN OPTION | 2018-09-18 | +$0 | $125,558 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00005· EXERCISE AN OPTION | 2018-10-01 | +$88,951 | $214,509 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-12-14 | −$28,339 | $186,170 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2019-06-06 | +$0 | $186,170 | IGF::OT::IGF - UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00008· EXERCISE AN OPTION | 2019-09-20 | +$0 | $186,170 | UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00009· FUNDING ONLY ACTION | 2019-10-01 | +$124,188 | $310,358 | UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2020-05-04 | −$58,025 | $252,333 | UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. DEOBLIGATION OF EXCESS FUNDS, OPTION YEAR TWO |
| Mod P00011· EXERCISE AN OPTION | 2020-09-01 | +$0 | $252,333 | UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. EXERCISE OPTION YEAR FOUR |
| Mod P00012· FUNDING ONLY ACTION | 2020-10-01 | +$124,188 | $376,521 | UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. FUND OPTION YEAR FOUR |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2021-01-27 | +$0 | $376,521 | UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. DEOBLIGATE (REMOVE) EXCESS FUNDS / OPTION YEAR THREE (… |
| Mod P00014· OTHER ADMINISTRATIVE ACTION | 2022-02-10 | −$29,772 | $346,750 | UPS797 TESTING FOR PHARMACY - BILOXI, MS&PENSACOLA, FL. DEOBLIGATE (REMOVE) EXCESS FUNDS / OPTION YEAR FOUR |
Related awards · 6
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GQN7WKAKUFM1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026P0357 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · H265 · EQUIPMENT AND MATERIALS TESTING- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $4,303 | FY2026 |
| 36C24126P0150 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · F107 · ENVIRONMENTAL SYSTEMS PROTECTION- TOXIC AND HAZARDOUS SUBSTANCE ANALYSIS | $27,527 | FY2026 |
| 36C25622P1646 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · H266 · EQUIPMENT AND MATERIALS TESTING- INSTRUMENTS AND LABORATORY EQUIPMENT | $443,527 | FY2022 |
| 36C26021F0294 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · H265 · EQUIPMENT AND MATERIALS TESTING- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $133,730 | FY2021 |
| 36C24121C0010 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · F107 · ENVIRONMENTAL SYSTEMS PROTECTION- TOXIC AND HAZARDOUS SUBSTANCE ANALYSIS | $204,228 | FY2021 |
| 36C25020C0087 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · L066 · TECHNICAL REPRESENTATIVE- INSTRUMENTS AND LABORATORY EQUIPMENT | $58,531 | FY2020 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25616F1739_3600_GS07F0721X_4732 · retrieved 2026-09-26.